<DOC>
	<DOCNO>NCT00374088</DOCNO>
	<brief_summary>The purpose study determine whether intravenous N-acetylcysteine ( also know Acetadote ) , antioxidant medication use year treat Tylenol overdose , help prevent heart dysfunction early postoperative period follow congenital heart surgery . Children undergo major heart surgery , arterial switch operation , routinely develop temporary heart dysfunction first 12-24 hour surgery . This heart dysfunction may severe contributes increase risk death prolonged hospitalization . Current standard treatment include intravenous medication dopamine , epinephrine , vasopressin support child 's blood pressure heart function . Unfortunately , high dos medication potential cause severe side effect include loss finger toe , liver kidney dysfunction , heart rhythm abnormality . Our goal find way reduce heart dysfunction major heart surgery order promote smoother postoperative period , reduce risk associated heart operation child .</brief_summary>
	<brief_title>N-Acetylcysteine Neonatal Congenital Heart Surgery ( INACT Study )</brief_title>
	<detailed_description>This randomize , placebo-controlled , blind study intravenous N-acetylcysteine ( NAC ) prevention postoperative myocardial dysfunction apoptosis infant undergo arterial switch D-transposition great artery . Subjects age 0-3 month , distinction make base gender race . Infants operate 36 week post-conceptional age birth weight less 1.8 kilogram exclude . Informed consent obtain patient 's parent one investigator hospital infant undergo surgery . Subjects randomize base block randomization scheme receive placebo NAC infusion , start load dose 1 hour prior surgery . If concern ICU physician patient develop toxicity medicine , study drug discontinue patient remove study . Patients thermodilution catheter place surgery postoperative direct measurement cardiac output . Endomyocardial biopsy perform surgeon pre- post-bypass measurement marker apoptosis . Postoperatively , patient continue receive infusion IV NAC 24 hour . Blood draw exist arterial central venous catheter . Serum lab collect include serial lactate value ( already collect routinely ) , liver renal function test , CK-MB troponin-I level marker myocardial injury , S100b level marker brain injury . Total additional blood remove research purpose less 15 mL . Cardiac output measure serially thermodilution . Serial transthoracic echocardiography use determine leave ventricular function . Inotropic score , duration mechanical ventilation , length ICU stay , length hospitalization record .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Transposition Great Vessels</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>All patient transfer born C.S . Mott Children 's Hospital 0 3monthsold undergoing ASO dTGA anatomic variant ( include doubleoutlet right ventricle transposition physiology ) . Less 36weeks postconceptional age time enrollment Birth weight le 1800 gram ; Evidence significant renal , hepatic , neurological dysfunction Additional significant cardiac lesion patent ductus arteriosus , isolate ventricular septal defect , simple coarctation , and/or atrial septal defect Preoperative extracorporeal membrane oxygenation ( ECMO ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Months</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>N-acetylcysteine</keyword>
	<keyword>Myocardial dysfunction</keyword>
	<keyword>Transposition Great Arteries</keyword>
</DOC>